Geriatric Medicine Doctors in Schererville, IN Accepting Medicare

1 Geriatric Medicine doctors found. Showing 1 - 1

Brent Cutro, DO Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W. Lincoln Highway, Schererville, IN 46375 Phone: 219-322-3311

News Archive

McMaster researchers explore how surgeon's experience influences choice of surgery for patients

Researchers at McMaster University (Hamilton, ON) explored whether a surgeon's expertise influences procedural choice. The results of a new study of more than 8000 non-small cell lung cancer (NSCLC) patients undergoing surgical resection by 124 physicians showed that surgeons who perform more surgeries are less likely to perform high-risk pneumonectomies. Christian J. Finley, MD, MPH, will be presenting the results of this research at the 95th AATS Annual Meeting in Seattle, WA on April 28, 2015.

Also in Global Health News: Uganda malaria efforts; child mortality in Vietnam; refugee health; U.S. aid to Somalia; HIV in South Africa

The Guardian examines efforts to reduce malaria in Katine, Uganda, through the distribution of insecticide-treated nets to high-risk groups. Though the article details a reduction in the number of malaria cases in the region, additional nets are needed to cover the entire population. Also, health experts warn additional strategies, such as indoor residual spraying and increased access to drugs are needed to defeat malaria (Kavuma, 10/8).

Discovery of chemical profiles for infectious diarrhoea

Academics from the Universities of the West of England and Bristol have found that faeces from healthy people and those with infectious diarrhoea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).

Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drug

Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.

Scientists develop unique "switch" that can control the activity of any protein

Our bodies could not maintain their existence without thousands of proteins performing myriad vital tasks within cells. Since malfunctioning proteins can cause disease, the study of protein structure and function can lead to the development of drugs and treatments for numerous disorders.

Read more Medical News

› Verified 7 days ago